Clinical Trial Update: Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients [Phase 3]

View source ↗

Summary

A Phase 3 double-blind study compared mitiglinide with nateglinide in patients with Type 2 diabetes and has completed. The update confirms the trial status but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Mitiglinide (mitiglinide)
• Nateglinide (nateglinide)

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Diabetes | Phase 3 | Status: COMPLETED